1. Resolution WHA68.7. Global action plan on antimicrobial resistance. In: Sixty-eighth World Health Assembly, Geneva, 18–26 May 2015. Resolutions and decisions, annexes. Geneva: World Health Organization; 2015. Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA68/A68_R7-en.pdf [cited 2017 Nov 7].
2. Antimicrobial resistance. Report by the Secretariat. A70/12. Geneva: World Health Organization; 2017. Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA70/A70_12-en.pdf[Cited 2017 Jun 27].
3. Member State mechanism on substandard/spurious/falsely-labelled/falsified/counterfeit/medical products. EB140/23. Report submitted to the 140th session of the Executive Board. Geneva: World Health Organization; 2017. Available from: http://apps.who.int/gb/ebwha/pdf_files/EB140/B140_23-en.pdf[cited 2017 Oct 31].
4. Microbiological effects of sublethal levels of antibiotics.;Andersson;Nat Rev Microbiol,2014
5. The resistance phenomenon in microbes and infectious disease vectors: implications for human health and strategies for containment [workshop summary]. Institute of Medicine; Board on Global Health; Forum on Emerging Infections; Knobler SL, Lemon SM, Najafi M, et al., editors. Washington DC: National Academies Press; 2003. Available from: https://www.ncbi.nlm.nih.gov/books/NBK97126/[cited 2017 Jun 27].